STADA Georgia
About STADA
STADA is an international pharmaceutical company that has been pursuing its mission for more than 130 years: caring for people's health by building trusting relationships with partners and consumers. STADA's key business areas are Consumer Healthcare (CHC) products, generics and specialty medicines (including biosimilars). STADA products are available in more than 120 countries worldwide.
In 2022, the CIS region became an independent business unit and was renamed STADA Eurasia, reporting directly to the headquarters in Germany. The region comprises 11 countries: Kazakhstan, Uzbekistan, Belarus, Azerbaijan, Georgia, Moldova, Kyrgyzstan, Armenia, Mongolia, Tajikistan and Turkmenistan.
STADA
130 years of STADA experience in caring for people's health
Across the region
STADA Eurasia
STADA Eurasia's head office is located in Almaty, Kazakhstan. The company has also registered STADA Arzneimittel AG legal entities in most countries in the region. Since 1 April 2023, STADA has represented Sanofi's portfolio of over-the-counter medicines in the region.
OUR PRODUCTS
Quality medicines for a better life
We offer a broad range of high-quality generics and consumer health products across different therapeutic areas.
0
products in catalog
6
therapeutic areas
Our values
Principles for daily decisions
Entrepreneurship
Agility
One STADA
News
Company news
STADA news, media stories, and product updates in one dynamic section.
01
/
--
2025
CapVest acquires a controlling stake in STADA from Bain Capital and Cinven
The transaction opens a new stage of group development and strengthens STADA's long-term international strategy.
2024
STADA's growth journey continued in 2024 with significant increases in sales and profit.
The company continues to deliver stable growth ahead of pharmaceutical market dynamics.
GE
Trusted dialogue between patients and healthcare professionals remains essential in Georgia.
Prevention, accessible information, and open communication with professionals are foundations of everyday health.
2025
STADA recognized as Top Employer Europe 2025
The recognition reflects a culture of growth, care for employees, and development opportunities for STADA teams.
STADA
STADA's portfolio combines strong consumer brands and generics
The product line helps support patients' health across different therapeutic areas.
Digestive
Enterogermina supports microflora health
The probiotic area remains an important part of STADA's everyday health solutions.
Cold season
Coldrex remains a recognizable brand in cold season
Products for relief of cold symptoms help patients maintain their usual rhythm of life.
Wellbeing
Vitrum Immunaktiv in focus for daily support
Vitamin and mineral complexes complement the product portfolio for wellbeing.
Careers
Careers at STADA
Working at STADA is a unique journey. We offer diverse roles from entry-level opportunities for graduates to expert positions across supply chain, marketing, finance, project management, and more.
>50%
leaders are women
94%
employees are proud of our purpose: caring for people's health as a trusted partner
>11 600
employees worldwide
93
nationalities in our team
Top 6%
top pharmaceutical companies in the Sustainalytics ESG 2023 rating